Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















гипертермия при лечении онкологии

1491 patient with a cancer has taken part in research BCRIG01 dairy железы with positive axillary лимфоузлами; middle age has made 49 years, 62 % of patients had from 1 up to 3 лимфоузлов, at 69 % of a tumour were рецепторопозитивными on РЭ and РП, at 20 % - positive on HER2/neu. All patients having positive РЭ and РП, received also тамоксифен in a doze of 20 mg / ЯТФ. Within 5 years. The median of time of supervision at the moment of the analysis of results has made 33 (0-49) months. Подробнее...

For acknowledgement{confirmation} of some positions it is necessary to continue molecular and цитогенетические researches on all tumours аногенитальной the zones, connected with ВПЧ. Now, after accumulation of a plenty epidemiological and эксперементальных the data, РШМ it is represented by unique model for studying virus канцерогенеза and definitions of associations between молекулярно-genetic changes caused by a virus and features of clinical current and the forecast of disease. Подробнее...